about
Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ splenocytes.Pharmacological Evaluation of the SCID T Cell Transfer Model of Colitis: As a Model of Crohn's Disease.New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy.Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report.Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation.Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review.Gastro-intestinal autoimmunity: preclinical experiences and successful therapy of fistulizing bowel diseases and gut Graft versus host disease by mesenchymal stromal cells.Tumour necrosis factor antagonist and tuberculosis in patients with rheumatoid arthritis: an Asian perspective.Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanismChanges to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007).Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.
P2860
Q34553368-97D218FF-2330-44FE-8CF6-7D4A86E149B9Q35895310-42FD46F8-719C-4C82-987B-DB226BAC38F5Q37266540-2708ECBA-57A8-4505-9412-C2414B98277AQ37474234-6E9A659B-080B-4502-85E8-294CEB4EEBC5Q37810960-97B29B26-61E8-4AB2-AC46-B668A32D8FF7Q38053495-F300F82F-67A5-4D0C-A4C6-353D6BD72700Q38066213-E0B8EC68-4456-4333-A37A-8B1A45D0B3D2Q38072387-6358963A-C091-4F17-BB46-5C5B27EBC4C7Q38096939-EAB74B03-1BE2-40BB-A988-DF2156CDEFB8Q38102726-485230D1-646F-49C8-8824-5F6A13539668Q39249504-03E08B2D-86D6-4710-90E7-233EC0D1A5CEQ42717964-8534A0BE-251C-4F60-B8D5-8F375625325BQ46971232-CF3BBB9E-9E9A-4988-AA48-3C6A6D21D691Q51165811-1D94E7E3-DBE4-4CAD-854B-3AC042B93CBA
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Overview of biologic therapy for Crohn's disease.
@en
Overview of biologic therapy for Crohn's disease.
@nl
type
label
Overview of biologic therapy for Crohn's disease.
@en
Overview of biologic therapy for Crohn's disease.
@nl
prefLabel
Overview of biologic therapy for Crohn's disease.
@en
Overview of biologic therapy for Crohn's disease.
@nl
P2860
P1476
Overview of biologic therapy for Crohn's disease.
@en
P2093
Gerald W Dryden
P2860
P304
P356
10.1517/14712590903048909
P407
P577
2009-08-01T00:00:00Z